Table 5.
Type of management change in BCR cohort following 68Ga-THP-PSMA PET-CT
| Management plan pre-PSMA PET-CT | Patients who had management changed | New management plan post-PSMA PET-CT | Patients who did not have management changed |
|---|---|---|---|
| Surveillance | 3 | ADT (n = 1) | 11 |
| ADT and chemotherapy (n = 1) | |||
| SABR (n = 1) | |||
| RARP | 2 | Surveillance (n = 1) | 6 |
| ADT (n = 1) | |||
| Brachytherapy | 2 | Surveillance (n = 1) | 1 |
| Watchful waiting (n = 1) | |||
| SABR | 2 | EBRT (n = 1) | 5 |
| ADT (n = 1) | |||
| EBRT | 5 | Surveillance (n = 1) | 13 |
| ADT (n = 2) | |||
| SABR (n = 1) | |||
| RARP (n = 1) | |||
| ADT | 9 | Best supportive care (n = 1) | 9 |
| ADT and chemotherapy (n = 3) | |||
| Chemotherapy (n = 3) | |||
| EBRT (n = 1) | |||
| SABR (n = 1) |
ADT androgen deprivation therapy, SABR stereotactic ablative radiotherapy, EBRT external beam radiotherapy, RARP robotic-assisted radical prostatectomy